Sunday, May 24, 2015 5:42:45 PM
They can not produce material to restart Tox tests which are completely stalled at this point. They are stopped.
Even if BASi has the materials, they can not do the tests that the FDA requires because they do not exist. They have no way to test the toxicity in tissue. None. NNVC is "working" on developing tests, as was revealed in the last filing, but up until then nobody was aware that BASi told them they can't do the tests. Withholding that info is a criminal offense. Seymour is probably going to take the fall and he doesn't even know it.
Ebolacide2 was a complete waste of time, material and money, but did exactly what they needed it to do. It kept people's false hoipes alive, gave them another 6 months of no movement on Flucide and salary collection.
The lab is STILL not operational and certified. It is we'll over 12 months since the grand opening.
They announce non results from herbicide, just to add more distraction and confusion. Remember them saying they are laser focused on Flucide?
This drum beat of "just wait, results are coming soon" has been chanted for the past 9 years and they are truly not one step closer than they were then.
The lab is a money laundering machine. Diwan let it slip during the grand opening when he mis spoke and solicited business for any and all comers. I guess he forgot is was supposed to be for NNVC's use.
I have tried to warn you all about this and those who have listened have saved themselves from total ruin. Those who believe progress is being made are in for a very unfortunate truth.
The SwingTrade Portfolio is up 5.8% YTD through 01/27/15, 36.2% in 2014, 83.5% in 2013, and 546.6% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110307454
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM